Fan Zhang found that concentrations of CTSZ were linked to the outcomes of individuals with clear cell renal cell carcinoma (ccRCC) (hazard ratio = 1.5, P = 0.007), where elevated CTSZ levels corresponded to worse prognoses during anti-PD-1 monotherapy. Here, CTSZ is linked to nonpapillary renal cell carcinoma.